The store will not work correctly when cookies are disabled.
JavaScript seems to be disabled in your browser. For the best experience on our site, be sure to turn on Javascript in your browser.
2-naphthoic bis(2-oxooxazolidin-3-yl)phosphinic anhydride ID: ALA1208995
PubChem CID: 49862116
Max Phase: Preclinical
Molecular Formula: C17H15N2O7P
Molecular Weight: 390.29
Molecule Type: Small molecule
This compound is available for customization.
Associated Items:
Names and Identifiers Canonical SMILES: O=C(OP(=O)(N1CCOC1=O)N1CCOC1=O)c1ccc2ccccc2c1
Standard InChI: InChI=1S/C17H15N2O7P/c20-15(14-6-5-12-3-1-2-4-13(12)11-14)26-27(23,18-7-9-24-16(18)21)19-8-10-25-17(19)22/h1-6,11H,7-10H2
Standard InChI Key: JQQDASGKUSYEGC-UHFFFAOYSA-N
Molfile:
RDKit 2D
27 30 0 0 0 0 0 0 0 0999 V2000
1.7236 -6.5020 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
1.7219 -7.3265 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4383 -7.7396 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
2.4355 -6.0891 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1529 -6.4965 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.1541 -7.3244 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8671 -7.7346 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5838 -7.3187 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
4.5766 -6.4902 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
3.8628 -6.0815 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
5.2908 -6.0745 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.0064 -6.4804 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
5.2873 -5.2494 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.7184 -6.0654 0.0000 P 0 0 0 0 0 0 0 0 0 0 0 0
7.4308 -5.6456 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
7.1388 -6.7769 0.0000 N 0 0 0 0 0 0 0 0 0 0 0 0
8.0949 -6.1366 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.7623 -5.6551 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
8.5146 -4.8676 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.6885 -4.8665 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.9011 -7.5600 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.5779 -8.0369 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
8.2371 -7.5385 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
7.9698 -6.7598 0.0000 C 0 0 0 0 0 0 0 0 0 0 0 0
6.3044 -5.3528 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
7.2066 -4.1932 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
6.1192 -7.8309 0.0000 O 0 0 0 0 0 0 0 0 0 0 0 0
1 2 2 0
2 3 1 0
3 6 2 0
5 4 2 0
4 1 1 0
5 6 1 0
6 7 1 0
7 8 2 0
8 9 1 0
9 10 2 0
10 5 1 0
11 12 1 0
11 13 2 0
9 11 1 0
12 14 1 0
14 15 1 0
14 16 1 0
15 17 1 0
17 18 1 0
18 19 1 0
19 20 1 0
20 15 1 0
16 21 1 0
21 22 1 0
22 23 1 0
23 24 1 0
24 16 1 0
14 25 2 0
20 26 2 0
21 27 2 0
M END Associated Targets(Human) Associated Targets(non-human) Molecule Features Natural Product: NoOral: NoChemical Probe: NoParenteral: NoMolecule Type: Small moleculeTopical: NoFirst In Class: NoBlack Box: NoChirality: NoAvailability: NoProdrug: No
Drug Indications MESH ID MESH Heading EFO IDs EFO Terms Max Phase for Indication References
Mechanisms of Action Mechanism of Action Action Type target ID Target Name Target Type Target Organism Binding Site Name References
Calculated Properties Molecular Weight: 390.29Molecular Weight (Monoisotopic): 390.0617AlogP: 3.01#Rotatable Bonds: 4Polar Surface Area: 102.45Molecular Species: ┄HBA: 7HBD: ┄#RO5 Violations: ┄HBA (Lipinski): 9HBD (Lipinski): ┄#RO5 Violations (Lipinski): ┄CX Acidic pKa: ┄CX Basic pKa: ┄CX LogP: 2.34CX LogD: 2.34Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.74Np Likeness Score: -0.34
References 1. Lee S, Jung KY, Park J, Cho JH, Kim YC, Chang S.. (2010) Synthesis of potent chemical inhibitors of dynamin GTPase., 20 (16): [PMID:20621477 ] [10.1016/j.bmcl.2010.06.092 ]